The call for electronic recordskeeping has become more insistent.

The 9th biannual continuing education meeting for optometrists sponsored by OCLI introduced a new feature-roundtables.

Orlando has no shortage of creative culinary choices for a special night on the town.

The reason why some optometry practices stay stuck in neutral, don't grow, or don't increase profits often involves the optometrist's lack of knowledge and application of one important business practice: marketing.

During tough economy, some try to economize by cutting back on medication use.

One optometrist has been on a mission for 25 years to develop and grow generations of paraoptometrics.

A particular fixed-combination ophthalmic solution for glaucoma effectively controls IOP and potentially may increase patient adherence to therapy, an issue commonly associated with multi-drug regimens for the disease.

The FDA has approved bepotastine besilate ophthalmic solution 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients aged 2 or more years.

Visual field instruments have changed in their abilities to detect fundus abnormalities.

A variety of skills and devices can enable patients with low vision in performing near and distance vision tasks.

Electronic health records are only part of the process of going paperless.

Jeffrey P. Gilbard, MD, founder, chief executive officer, and chief scientific officer of Advanced Vision Research, died Aug. 12, following complications from a bicycling accident.

Results from Age-Related Eye Disease Study have drawn attention to the role of nutritional supplementation in the management of eye disease.

Overcoming generational differences means not only understanding each generation, but respecting them all.

By the year 2030, the elderly population of the United States is projected to more than double, from 35 million to 72 million people.

Screening for glaucoma has not been done on a large scale due to cost and a generally low prevalence of the disease.

Age-related macular degeneration (AMD) is a growing problem throughout the world and is influenced by genetics and behavior.

Abbott is to acquire Visiogen in a $400 million cash deal that includes next-generation accommodating IOL technology to address presbyopia for cataract patients.

Diabetes mellitus and systemic hypertension affect tens of millions of Americans, and tens of millions more are at risk for these serious diseases that are leading causes of morbidity and mortality.

A new software program that automatically aligns digital retinal or optic nerve photographs taken several years apart and alternates them to allow clinicians to look for changes over time may improve the speed and accuracy of glaucoma diagnosis.